What is Janux Therapeutics's stock issuance proceeds?

Janux Therapeutics (JANX) reported stock issuance proceeds of $3.55M in Q1 2026.

How has Janux Therapeutics's stock issuance proceeds changed year-over-year?

Janux Therapeutics's stock issuance proceeds increased by 293.5% year-over-year, from $901K to $3.55M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Janux Therapeutics JANX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron PharmaceuticalsREGN

$163.1M+169%

XencorXNCR

$950K-68.1%

Cullinan Therapeutics, Inc.CGEM

$0-100%

Nektar TherapeuticsNKTR

$1.07B+506,582%

Arcus BiosciencesRCUS

$0-100%

ImmunomeIMNM

$229K+7.5%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.3%

Enterprise value$862.55M-36.2%

P/S65×-85.2×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's stock issuance proceeds?: Janux Therapeutics (JANX) reported stock issuance proceeds of $3.55M in Q1 2026.
How has Janux Therapeutics's stock issuance proceeds changed year-over-year?: Janux Therapeutics's stock issuance proceeds increased by 293.5% year-over-year, from $901K to $3.55M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.